Tag: Humacyte FDA approval

news-14082024-234924

Humacyte Stock Drops 18% Due to FDA Delay for ATEV (NASDAQ:HUMA)

Humacyte, a biotechnology company listed on the NASDAQ under the ticker symbol HUMA, experienced a significant drop in its stock price of 18% in after-hours trading on Friday. This decline came as a result...

FINANCE & STOCK NEWS

BREAKING NEWS

jay-powell-downplays-growth-worries-after-disappointing-jobs-report

How AI is Revolutionizing Financial Services

FintechZoom.io has been at the forefront of analyzing how Artificial Intelligence (AI) is transforming financial services. From automating operations to enhancing risk management and...

ADVERTISEMENT

Top News

CRYPTO NEWS & MAGAZINE